The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Patterns of chronic benzodiazepine use in the elderly
Open accessAbstract
Background In several countries, prevalence studies demonstrate that chronic use of BZD in the elderly population is very high. This scenario has reached pandemic proportions for decades and is an important public health problem. Objectives To examine the independent association between chronic benzodiazepine use in depression, anxiety and bipolar disorder, as well as other clinical and sociodemographic factors. Methods This cross-sectional study was developed from a population-based survey and conducted from March, 2011 to December, 2012 using a random sample of 550 elderly people who were enrolled in the Family Health Strategy in Porto Alegre, Brazil. Data was collected from identifying epidemiological and health data (sociodemographic, self-perception health, self-reported diseases, smoking, alcohol and pharmacotherapeutic evaluation) and from the diagnoses of mood and anxiety disorders. Results Elderly patients diagnosed with depression, anxiety, concomitant depression/anxiety and bipolar disorders, and those who were using antidepressants have a higher risk of benzodiazepine use. Individuals who self-reported drinking alcohol had a lower risk of benzodiazepine use. Discussion Benzodiazepines are often used by the elderly for long periods, which has a direct impact on the treatment of mood and anxiety disorders and on vulnerable groups such as the elderly, who may be unnecessarily taking these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite this, some psychotropics are used far longer than recommended or without appropriate, documented reasons [29–31].”
From Stakeholders' views on the use of psychotropic medication in older people: a systematic review (2022) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Benzodiazepine harm: how can it be reduced?
Lader, M. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04418.x · Cited by 359
“Psychiatric comorbidity”: an artefact of current diagnostic systems?
Maj, M. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.3.182 · Cited by 305
Barbui, C., Cipriani, A., Patel, V., Ayuso‐Mateos, J. L., & van Ommeren, M. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076448 · Cited by 216
Dell’osso, B., & Lader, M. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.003 · Cited by 210
Richardson, K., Bennett, K., & Kenny, R. A. (2014) · Age and Ageing · doi:10.1093/ageing/afu141 · Cited by 183
Marques, J. M. D. A., & Zuardi, A. W. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.02.001 · Cited by 156
Weisberg, R. B., DYCK, I. R., Culpepper, L., & Keller, M. B. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.276 · Cited by 120
Manthey, L., van Veen, T., Giltay, E. J., Stoop, J. E., Neven, A. K., Penninx, B. W. J. H., & Zitman, F. G. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03818.x · Cited by 113
Barcelos‐Ferreira, R., Izbicki, R., Steffens, D. C., & Bottino, C. M. C. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210000463 · Cited by 107
Research works printed but not linked: 6
- Greenblatt DJ, Harmatz JS, Shader RI. Psychotropic drug prescribing in the United States: extent, costs, and expenditures. J Clin Psychopharmacol. 2011;31(1):1-3.
- Nogueira EL, Rubin LL, Giacobbo SS, Gomes I, Cataldo Neto A. Rastreamento de sintomas depressivos em idosos na Estratégia Saúde da Família, Porto Alegre. Rev Saúde Pública. 2014;48(3):368-77.
- Nogueira EL, Moretti PF, Ribeiro Junior FP, Diefenthaeler EC, Cataldo Neto A, Engroff P, et al. The Mental Health Research Protocol of the Multidimensional Study of the Elderly in the Family Health Strategy in Porto Alegre, Brazil (EMI-SUS). Pan Am J Aging Res. 2014;2(1):29-34.
- Amorim P. Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev Bras Psiquiatr. 2000;22(3):106-15.
- Alvarenga JM, Loyola Filho AI, Firmo JOA, Lima-Costa MF, Uchoa E. Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambuí Health and Aging Study (BHAS). Rev Bras Psiquiatr. 2008;30(1):7-11.
- American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616-31.
Cited by
Zuardi, A. W., Rodrigues, N. P., Silva, A. L., Bernardo, S. A., Hallak, J. E. C., Guimarães, F. S., & Crippa, J. A. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00259 · Cited by 294
Ng, B. J., Le Couteur, D. G., & Hilmer, S. N. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0544-4 · Cited by 118
Stakeholders' views on the use of psychotropic medication in older people: a systematic review
Bednarczyk, E., Cook, S., Brauer, R., & Garfield, S. (2022) · Age and Ageing · doi:10.1093/ageing/afac060 · Cited by 22
Burry, L. D., Turner, J. P., Morgenthaler, T. I., Tannenbaum, C., Cho, H. J., Gathecha, E., Kisuule, F., Vijenthira, A., & Soong, C. (2021) · Annals of Pharmacotherapy · doi:10.1177/10600280211033022 · Cited by 19
Chen, Y., Liu, C.-Y., Chang, C., Lai, Y., Wang, B., Yang, T., & Hsu, S. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.077 · Cited by 15
Metadata
- Authors
- Sgnaolin, V., Engroff, P., Andrade, C. P., Loureiro, F., Nogueira, E. L., Cataldo Neto, A., & Gomes, I.
- Affiliations
- Pontifícia Universidade Católica do Rio Grande do Sul (BR)
- Hospital São Lucas da PUCRS (BR)
- Corresponding author
- Sgnaolin, Vanessa
- ORCID
- Venue
- Archives of Clinical Psychiatry (São Paulo)
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2016-08
- Volume
- 43
- Issue
- 4
- Pages
- 79-82
- ISSN
- 0101-6083 (ISSN-L)
- 1806-938X
- OpenAlex
- W2535026479
- Cited by
- 11
- References
- 22
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 1
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Archives of Clinical Psychiatry (São Paulo) (publishedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- PUCRS Repository (Pontifical Catholic University of Rio Grande do Sul) (submittedVersion, cc-by-nc-sa)
- The Scientific Electronic Library Online (Fundação de Amparo à Pesquisa do Estado de São Paulo) (submittedVersion, other-oa)
- Funders
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
- Ciência sem Fronteiras
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- chronic benzodiazepine use, older adults, depression, anxiety disorders, bipolar disorder, antidepressant use, alcohol consumption, mood disorders, sociodemographic factors, inappropriate prescribing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patterns of chronic benzodiazepine use in the elderly. https://app.cochat.ai/papers/10.1590/0101-60830000000089
- The paper
- Sgnaolin, V., Engroff, P., Andrade, C. P., Loureiro, F., Nogueira, E. L., Cataldo Neto, A., & Gomes, I. (2016). Patterns of chronic benzodiazepine use in the elderly. Archives of Clinical Psychiatry (São Paulo). https://doi.org/10.1590/0101-60830000000089
